Acurx Pharmaceuticals, Inc. Skyrocketed
Acurx Pharmaceuticals, Inc. (ACXP:NASDAQ) shot up at $2.9, a gain of 48.3%. On Tue, Mar 10, 2026, ACXP:NASDAQ touched a New 2-Week High of $2.9. The stock got featured on our News Catalysts scanner on Mon, Mar 09, 2026 at 09:56 AM in the 'BIOTECH' category. From Tue, Feb 24, 2026, the stock recorded 50.00% Up Days and 36.36% Green Days
The stock spiked on Wed, Oct 08, 2025 at $8.34 with a volume of 24M+.
About Acurx Pharmaceuticals, Inc. (ACXP:NASDAQ)
Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health...
Top 10 Gainers:
- Agape ATP Corporation (ATPC:NASDAQ), 87.13%
- Polaryx Therapeutics Inc. (PLYX:NASDAQ), 69.6%
- Longeveron Inc. (LGVN:NASDAQ), 68.27%
- Decent Holding Inc. (DXST:NASDAQ), 50.42%
- Acurx Pharmaceuticals, Inc. (ACXP:NASDAQ), 48.34%
- MacroGenics, Inc. (MGNX:NASDAQ), 45.34%
- Nauticus Robotics, Inc. (KITT:NASDAQ), 42.46%
- Zenvia Inc. (ZENV:NASDAQ), 41.33%
- N2OFF, Inc. (NITO:NASDAQ), 38.64%
- Murano Global Investments Plc (MRNO:NASDAQ), 38.08%